• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性心肌梗死直接血管成形术后患者出院判定中的手术成功率与临床风险状态

Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarction.

作者信息

Heggunje Prabhakara S, Harjai Kishore J, Stone Gregg W, Mehta Rajendra H, Marsalese Dominic L, Boura Judith A, O'Neill William W, Grines Cindy L

机构信息

William Beaumont Hospital, Royal Oak, Michigan 48073-6769, USA.

出版信息

J Am Coll Cardiol. 2004 Oct 6;44(7):1400-7. doi: 10.1016/j.jacc.2004.06.065.

DOI:10.1016/j.jacc.2004.06.065
PMID:15464319
Abstract

OBJECTIVES

We evaluated whether patients' clinical status, angioplasty success, or both, should guide discharge after primary angioplasty (i.e., percutaneous coronary intervention [PCI]) for acute myocardial infarction (AMI).

BACKGROUND

Current guidelines do not address a discharge strategy for AMI patients undergoing successful PCI.

METHODS

Patients who underwent PCI in Primary Angioplasty in Myocardial Infarction (PAMI) studies (N = 3,188) were classified as "high clinical risk" if they had either age >70 years, Killip class >1, heart rate >100 beats/min, systolic blood pressure <100 mm Hg, anterior MI, or left bundle branch block, and as "low clinical risk" if none was present. Successful PCI patients were compared with those with unsuccessful PCI in both groups for 30-day major adverse cardiac events (MACE).

RESULTS

Percutaneous coronary intervention was successful in 668 (90%) of 745 low-risk clinical and 2,104 (86%) of 2,443 high-risk clinical patients. Regardless of clinical risk status, patients with successful PCI had lower 30-day MACE than those with unsuccessful PCI (low-risk group: 4.6% vs. 22%, p < 0.0001; high-risk group: 7% vs. 21%; p < 0.0001). Moreover, successful PCI patients with either risk status had few MACE after day 4, whereas unsuccessful PCI patients had more MACE. The success of PCI was the strongest independent predictor of 30-day MACE (odds ratio [OR] 3.7, 95% confidence interval [CI] 2.8 to 5.0). A constellation of three or more high-risk clinical features also predicted higher 30-day MACE (OR 2.25, 95% CI 1.62 to 3.12).

CONCLUSIONS

The success of PCI is the prime determinant of clinical outcome after PCI for AMI. The majority of AMI patients with less than three high-risk clinical features who undergo successful PCI may be discharged from the hospital by day 4. In contrast, patients with more than two high-risk clinical features or unsuccessful PCI may need longer observation.

摘要

目的

我们评估了在急性心肌梗死(AMI)的直接血管成形术(即经皮冠状动脉介入治疗[PCI])后,患者的临床状况、血管成形术是否成功或两者是否都应作为出院的指导依据。

背景

当前指南未涉及接受成功PCI的AMI患者的出院策略。

方法

在心肌梗死直接血管成形术(PAMI)研究中接受PCI的患者(N = 3188),若年龄>70岁、Killip分级>1、心率>100次/分钟、收缩压<100 mmHg、前壁心肌梗死或左束支传导阻滞,则被分类为“高临床风险”,若不存在上述任何一项,则被分类为“低临床风险”。在两组中,将成功进行PCI的患者与未成功进行PCI的患者进行30天主要不良心脏事件(MACE)的比较。

结果

745例低风险临床患者中有668例(90%)、2443例高风险临床患者中有2104例(86%)的经皮冠状动脉介入治疗成功。无论临床风险状况如何,成功进行PCI的患者30天MACE发生率均低于未成功进行PCI的患者(低风险组:4.6%对22%,p<0.0001;高风险组:7%对21%;p<0.0001)。此外,无论风险状况如何,成功进行PCI的患者在第4天后发生的MACE较少,而未成功进行PCI的患者发生的MACE较多。PCI的成功是30天MACE最强的独立预测因素(优势比[OR] 3.7,95%置信区间[CI] 2.8至5.0)。三种或更多高风险临床特征的组合也预示着30天MACE发生率更高(OR 2.25,95% CI 1.62至3.12)。

结论

PCI的成功是AMI患者PCI后临床结局的主要决定因素。大多数接受成功PCI且具有少于三种高风险临床特征的AMI患者可能在第4天出院。相比之下,具有两种以上高风险临床特征或PCI未成功的患者可能需要更长时间的观察。

相似文献

1
Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarction.急性心肌梗死直接血管成形术后患者出院判定中的手术成功率与临床风险状态
J Am Coll Cardiol. 2004 Oct 6;44(7):1400-7. doi: 10.1016/j.jacc.2004.06.065.
2
Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?β受体阻滞剂治疗能否改善直接经皮冠状动脉腔内血管成形术后急性心肌梗死的临床结局?
J Am Coll Cardiol. 2004 May 19;43(10):1773-9. doi: 10.1016/j.jacc.2003.09.071.
3
Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.替罗非班上游治疗与下游治疗对高危急性冠状动脉综合征患者行经皮冠状动脉介入治疗后心肌损伤及 180 天临床结局的影响。
Chin Med J (Engl). 2009 Aug 5;122(15):1732-7.
4
Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.替罗非班辅助治疗对接受直接经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者的临床益处。
Coron Artery Dis. 2008 Jun;19(4):271-7. doi: 10.1097/MCA.0b013e3282f487e0.
5
Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.一项前瞻性多中心随机试验,比较急性ST段抬高型心肌梗死患者在进行直接经皮冠状动脉介入治疗时由医生转运与由患者转运的情况。
Chin Med J (Engl). 2008 Mar 20;121(6):485-91.
6
Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.急性心肌梗死患者接受直接血管成形术时的对比剂肾病
J Am Coll Cardiol. 2004 Nov 2;44(9):1780-5. doi: 10.1016/j.jacc.2004.07.043.
7
Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.多支血管病变对急性心肌梗死接受直接经皮冠状动脉介入治疗患者再灌注成功率及临床结局的影响。
Eur Heart J. 2007 Jul;28(14):1709-16. doi: 10.1093/eurheartj/ehm184. Epub 2007 Jun 7.
8
Outcomes of primary percutaneous coronary intervention for acute ST-elevation myocardial infarction in patients aged over 75 years.75岁以上急性ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗的结果
Chin Med J (Engl). 2006 Jul 20;119(14):1151-6.
9
Importance of complex additional stenosis after primary angioplasty for acute myocardial infarction in medium-term prognosis.急性心肌梗死初次血管成形术后复杂附加狭窄对中期预后的重要性。
Rev Port Cardiol. 2004 Jun;23(6):853-64.
10
Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score.急性心肌梗死直接经皮冠状动脉介入治疗后死亡率的预测:CADILLAC风险评分
J Am Coll Cardiol. 2005 May 3;45(9):1397-405. doi: 10.1016/j.jacc.2005.01.041.

引用本文的文献

1
Comparison of RISK-PCI, GRACE, TIMI risk scores for prediction of major adverse cardiac events in patients with acute coronary syndrome.急性冠状动脉综合征患者中RISK-PCI、GRACE、TIMI风险评分对主要不良心脏事件预测的比较。
Croat Med J. 2017 Dec 31;58(6):406-415. doi: 10.3325/cmj.2017.58.406.
2
Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score.直接经皮冠状动脉介入治疗后的早期出院:N末端脑钠肽前体对兹沃勒风险评分的附加价值。
J Am Heart Assoc. 2014 Nov 11;3(6):e001089. doi: 10.1161/JAHA.114.001089.
3
Early discharge after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后的早期出院。
Eur Heart J Acute Cardiovasc Care. 2013 Sep;2(3):262-9. doi: 10.1177/2048872612475231.
4
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients.因子 XIIIA-V34L 和因子 XIIIB-H95R 基因变异:对心肌梗死患者生存率的影响
Mol Med. 2007 Jan-Feb;13(1-2):112-20. doi: 10.2119/2006-00049.Gemmati.